Clinical Trial Update: RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma [NA]

View source ↗

Summary

An ongoing randomized trial compares intralesional rituximab injections with involved-site radiotherapy for primary ocular adnexal MALT lymphoma; recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Adnexal Malt Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University | Conditions: Primary Ocular Adnexal MALT Lymphoma | NA | Status: RECRUITING